Cogent Biosciences, Inc. financial statements
Cogent Biosciences, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 0 | EODHD |
| Net income | −USD 328.94M | 10-K |
| Cash and equivalents | USD 312.01M | 10-Q |
| Total debt | USD 222.9M | 10-K |
Cogent Biosciences, Inc. financials on 6ix · Cogent Biosciences, Inc. on 6ix